Areas of Expertise

Intellectual Property, Technology & Telecommunications, Privacy, Competition & Consumer Law, Franchising, Procurement

Matthew has specialised in intellectual property, technology and corporate commercial law since 2001.

He is regularly retained to act on IP, information technology, procurement, competition and consumer, franchising and privacy law matters.

Matthew has a particular interest in the commercialisation and procurement of all kinds of IP and technology and focuses on non-contentious commercial and transactional work. He also has broad-based experience in the effective non-court resolution of disputes.  Matthew’s ICT expertise is underpinned by a decade’s prior experience in the IT industry.

Matthew has acted for several loyal clients over many years including ad agencies, media companies, ISPs, telecommunications carriers, cosmetics companies, credit providers, software developers, transport and logistics providers, wine producers, franchisors (particularly in the retail, food, hospitality, agribusiness and motor vehicle sectors), health, biotechnology and pharmaceutical companies, and technology start-ups.  ASX-listed clients include a number of medical device manufacturers and mining, resources, and energy companies.

Matthew's expertise extends to all forms of intellectual property and associated rights. His team manages the trade mark portfolios of an international hotel chain, a major Australian energy company, and a worldwide group of educational institutes.

What others say

"Recognised - Australia, IT and Telecoms"
Legal 500 Asia – Pacific 2018
"Leading Lawyer – South Australia, Intellectual Property"
Doyle's Guide 2018 – 2019
"Recommended Lawyer – South Australia, Intellectual Property"
Doyle's Guide 2017 & 2020
"Leading Lawyer – Australia, Intellectual Property Law"
Best Lawyers Peer Review 2019 – 2024



Acting for Internode and its shareholders on its sale to ASX-listed iiNet Limited for in excess of A$100 million.

LBT Innovations

Assisting ASX-listed LBT Innovations throughout the development, prototyping, and commercialisation of its medical technology products. Recently assisted in concluding a A$6 million joint venture based in Switzerland to develop and distribute a diagnostic imaging device.


Acting for Novozymes, a world-leading producer of industrial enzymes headquartered in Copenhagen, in a strategic investment in a Sydney-based biotech company based on a target valuation of US$35 million.


Acting for oOh!media, an outdoor media company, on over 25 discrete business acquisitions (each ranging in price up to A$45 million) over several years.


Acting for Santos since 2009 on a range of assignments, mainly in the ambit of procurement, IP, and IT.

SA Medical Research Institute

Assisting the South Australian Health and Medical Research Institute with various commercial tasks including advising on clinical trial agreements, fundraising, and privacy law compliance